Brokerages Set Select Medical Holdings Co. (NYSE:SEM) Price Target at $20.20

Share on StockTwits

Select Medical Holdings Co. (NYSE:SEM) has been assigned an average rating of “Hold” from the eight research firms that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $20.20.

SEM has been the subject of several recent research reports. Credit Suisse Group set a $18.00 price objective on Select Medical and gave the stock a “hold” rating in a research report on Friday, November 1st. Royal Bank of Canada reaffirmed an “outperform” rating and set a $27.00 price objective on shares of Select Medical in a research report on Tuesday, January 28th. They noted that the move was a valuation call. Finally, ValuEngine cut Select Medical from a “hold” rating to a “sell” rating in a research report on Tuesday, January 7th.

In other news, Director Leopold Swergold sold 25,000 shares of the company’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $22.11, for a total transaction of $552,750.00. Following the completion of the transaction, the director now directly owns 222,815 shares of the company’s stock, valued at $4,926,439.65. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 19.50% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of SEM. Renaissance Technologies LLC boosted its position in Select Medical by 259.8% during the fourth quarter. Renaissance Technologies LLC now owns 873,700 shares of the health services provider’s stock valued at $20,392,000 after purchasing an additional 630,900 shares during the last quarter. Point72 Asset Management L.P. boosted its position in Select Medical by 14,292.5% during the fourth quarter. Point72 Asset Management L.P. now owns 446,167 shares of the health services provider’s stock valued at $10,414,000 after purchasing an additional 443,067 shares during the last quarter. Voya Investment Management LLC lifted its position in shares of Select Medical by 37.7% in the third quarter. Voya Investment Management LLC now owns 1,307,844 shares of the health services provider’s stock valued at $21,671,000 after buying an additional 357,910 shares during the last quarter. Prudential Financial Inc. lifted its position in shares of Select Medical by 73.6% in the fourth quarter. Prudential Financial Inc. now owns 734,306 shares of the health services provider’s stock valued at $17,139,000 after buying an additional 311,290 shares during the last quarter. Finally, BlackRock Inc. lifted its position in shares of Select Medical by 1.2% in the second quarter. BlackRock Inc. now owns 16,931,926 shares of the health services provider’s stock valued at $268,711,000 after buying an additional 207,146 shares during the last quarter. 75.52% of the stock is owned by hedge funds and other institutional investors.

Shares of Select Medical stock traded up $2.12 during trading hours on Friday, hitting $28.21. The company’s stock had a trading volume of 2,161,861 shares, compared to its average volume of 908,811. Select Medical has a 12 month low of $12.96 and a 12 month high of $28.61. The stock has a 50 day moving average of $24.08 and a 200 day moving average of $20.05. The company has a market capitalization of $3.50 billion, a PE ratio of 25.65, a price-to-earnings-growth ratio of 1.34 and a beta of 1.33. The company has a debt-to-equity ratio of 4.61, a current ratio of 1.21 and a quick ratio of 1.21.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.11. The company had revenue of $1.37 billion during the quarter, compared to analysts’ expectations of $1.34 billion. Select Medical had a return on equity of 17.38% and a net margin of 2.72%. Select Medical’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.20 earnings per share. Equities analysts expect that Select Medical will post 1.39 EPS for the current year.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Further Reading: Initial Coin Offering (ICO)

Analyst Recommendations for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.